Dr. Kavitha Beedupalli, MD

Dr. Beedupalli practices at Ochsner LSU Health - Monroe Medical Center in Monroe, Louisiana, part of Ochsner Health System.

Dr. Beedupalli's NPI, 1568694321, was assigned on August 12, 2009. Dr. Beedupalli graduated from Mamata Medical College in 2003. Dr. Beedupalli holds Louisiana license MD.207830.

Dr. Beedupalli's primary practice is Ochsner LSU Health - Monroe Medical Center, at 4864 Jackson Street, Monroe, LA 71202 in Ouachita Parish. The practice phone is (318) 388-7000.

Dr. Beedupalli's primary practice is Ochsner LSU Health - Monroe Medical Center in Monroe, Louisiana, part of Ochsner Health System. Dr. Beedupalli is also affiliated with Willis Knighton North. The medical group on file is LSU Health Shreveport. Dmand AI also links Dr. Beedupalli to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beedupalli practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Beedupalli's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Beedupalli is licensed in Louisiana.

Dmand AI lists chronic anemia, fluid and electrolyte imbalances, lung cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Beedupalli treats.

CMS data shows 497 Medicare services from Dr. Beedupalli across 4 procedure codes in 2024, for 137 Medicare patients. Medicare paid $40,376 for them.

CMS counts 137 Medicare patients who saw Dr. Beedupalli in 2024. The largest group is 65 to 74, with 73 patients. 72% of them have high blood pressure, and 53% have cancer. 44% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beedupalli's median patient age at 68, with 49% women.

In 2024, Dr. Beedupalli wrote 97 Medicare Part D claims for 42 patients. 82% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $1,045 in total drug cost. In 2022, CMS named 107 claims across 6 drugs.

Dr. Beedupalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beedupalli as offering telehealth.

Dmand AI links 16 papers to Dr. Beedupalli, published from 2017 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Lung Neoplasms and Head and Neck Neoplasms. Dr. Beedupalli's most frequent co-authors are Paari Dominic, MBBS, Sahith Thotamgari and Dalia Hammoud, MD.

Dmand AI links Dr. Beedupalli to 6 clinical trials, 3 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma of Lung. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 328 general payments to Dr. Beedupalli from 45 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Genentech, Inc. paid the most, $9,308.

Dr. Beedupalli graduated from Mamata Medical College in 2003.

Dr. Beedupalli is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.